Tag: Australian biopharmaceutical company
Telix Pharmaceuticals announces establishment of Japanese subsidiary
Telix Pharmaceuticals has announced the establishment of a wholly-owned operating subsidiary in Japan to support its Japanese clinical and radiopharmaceutical manufacturing activities.
Telix Co-Founder and...
Immuron receives first USA orders for Travelan®
Australian biopharmaceutical company Immuron Limited has announced that it has secured first orders for its Travelan® product in the USA.
The order was from the...
Featured Article
Navigating energy price volatility with predictive intelligence
Energy price volatility has become a structural feature of modern electricity markets rather than a temporary disruption. For energy-intensive manufacturers and large commercial operators, fluctuating wholesale prices are reshaping how energy costs are managed, making reactive approaches increasingly inadequate.
